Impact of Ashwagandha in Obesity Parameters from Mexican Adults

Launched by IVAN LUZARDO-OCAMPO · Nov 4, 2024

Keywords

ClinConnect Summary

This clinical trial aimed to assess the impact of ashwagandha supplementation on serum lipid concentrations and body composition in Mexican adults with overweight and obesity through a double-blind, randomized, placebo-controlled protocol. The study included adult patients who met inclusion such as a Body Mass Index (BMI) of 25 kg/m\^2 or higher, glucose levels around 100 mg/dL, LDL-C levels of 160 mg/dL or higher, total cholesterol levels of 200 mg/dL or higher, HDL-C levels lower than 40 mg/dL, and triglyceride levels exceeding 150 mg/dL). Patients were excluded if they were pregnant, had...

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Participants who are willing to comply with the study guidelines for a 40-day period.
• • 2. Individuals who consent to undergo initial anthropometric and biochemical analyses.
• • 3. Participants willing to follow personalized meal plans.
• • 4. Individuals who agree to receive reminders and monitoring communication via email and/or text messages.
• Exclusion Criteria:
• • 1. Individuals with known allergies or intolerances to Withania somnifera or starch rice.
• • 2. Participants who are unable or unwilling to follow the daily supplementation regimen.
• • 3. Individuals with medical conditions that might interfere with the study results or pose a health risk when taking the supplement.
• • 4. Participants currently taking any other supplements or medications that could interfere with the study outcomes.